US Patent Issued to ORPHAGEN PHARMACEUTICALS on Dec. 9 for "RAR-Alpha compounds for inflammatory disease and male contraception" (California Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,177, issued on Dec. 9, was assigned to ORPHAGEN PHARMACEUTICALS INC. (San Diego).

"RAR-Alpha compounds for inflammatory disease and male contraception" was invented by Raj Kumar Raheja (Poway, Calif.), Paul Damian Crowe (Encinitas, Calif.), Haiyan Tao (San Diego) and Scott McNear Thacher (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modulators of retinoid acid receptor-alpha (RARAlpha) of formula (I) are provided herein, as well as pharmaceutical compositions and methods relating thereto."

The patent was filed on Dec. 17, 2020, under Application No. 17/786,399.

*For further information, including images, charts and tables, please visit:...